FMP

FMP

Enter

PCRX - Pacira BioSciences, ...

Financial Summary of Pacira BioSciences, Inc.(PCRX), Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for h

photo-url-https://financialmodelingprep.com/image-stock/PCRX.png

Pacira BioSciences, Inc.

PCRX

NASDAQ

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

26.1 USD

-0.67 (-2.57%)

About

ceo

Mr. Frank D. Lee

sector

Healthcare

industry

Drug Manufacturers - Specialty & Generic

website

https://www.pacira.com

exchange

NASDAQ

Description

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira Bi...

CIK

0001396814

ISIN

US6951271005

CUSIP

695127100

Address

5401 West Kennedy Boulevard

Phone

813 553 6680

Country

US

Employee

711

IPO Date

Feb 3, 2011

Summary

CIK

0001396814

Exchange

NASDAQ

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

695127100

ISIN

US6951271005

Country

US

Price

26.1

Beta

0.75

Volume Avg.

491.31k

Market Cap

1.21B

Shares

-

52-Week

25.76-48.6

DCF

70.27

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

29.33

P/B

-

Website

https://www.pacira.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest PCRX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep